Hims & Hers to offer generic semaglutide in Canada as Novo Nordisk patent lapses CNBC 2025-07-09 13:01 (updated 2025-07-09 15:36) Source Original site Novo Nordisk will lose its patent protection on its branded semaglutide drugs Ozempic and Wegovy in Canada after not paying a maintenance fee in 2019.